Triple Therapy for Type 2 Approved

| Jan 1, 2003

The U.S. Food and Drug Administration has approved a new indication for Glucovance (glyburide and metformin tablets), allowing the type 2 diabetes medication to be taken in combination with thiazolidinediones (TZDs) when adequate control is not achieved with diet and exercise.

According to an October 11, 2002, news release from Bristol-Myers Squibb (BMS), the drug's manufacturer, clinical studies report that 42 percent of people with type 2 diabetes taking Glucovance with Avandia (rosiglitazone) achieved an A1C level of 7% or less.

BMS cautions that, in rare cases, Glucovance can cause lactic acidosis (a buildup of lactic acid in the blood), which can be fatal. People should not take Glucovance if they have kidney problems; if they are over 80 years of age (unless their kidneys have been tested); if they are taking medication for heart failure; or if they are seriously dehydrated, have a serious infection or have had liver disease. The most common side effect is diarrhea. People should not take Avandia or other TZDs unless laboratory tests show normal liver function.

Click Here To View Or Post Comments

Categories: A1c Test, Diabetes, Diabetes, Food, Government & Policy, Type 2 Issues, Type 2 Medications

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.